Kazuaki Takabe, MD, PhD, FACS, Clinical Chief of Breast Surgery, Alfiero Foundation Chair and Breast Program Leader at Roswell Park Comprehensive Cancer Center, is in Washington, D.C., today as a leader of the 4th U.S.–Japan Clinical Trials in Oncology Workshop.
The workshop guides young scientists in all aspects of designing compelling and effective clinical research studies in order to develop new cancer therapies. Attendees will review key concepts underlying cancer therapeutic clinical trials and explore opportunities for facilitating networking and collaboration among investigators from academia, industry and government-sponsored agencies.
“One of the objectives of this workshop is to discuss and clarify the barriers that Japan is facing as it seeks to increase the number of clinical trials initiated there,” says Dr. Takabe, who is Co-Director of the workshop along with Naoko Takebe, MD, PhD, Medical Director of the National Cancer Institute’s Cancer Therapy Evaluation Program. “Another objective is to spur the participation of Japanese institutions in international trials and to facilitate these international collaborations.”
This year’s workshop will focus on precision medicine.
Annie Deck-Miller, Senior Media Relations Manager